Latest Close
$0.49
News
JSPR
Jasper Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to JSPR.
1y Change
-$1.84 (-79.08%)
Market Cap
$16,221,348.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
GlobeNewswire • Oct 15, 2026
Read articleJasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
GlobeNewswire • Oct 7, 2026
Read articleJasper Therapeutics Announces Key Regulatory and Clinical Appointments
GlobeNewswire • Sep 15, 2026
Read articleJasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire • Sep 9, 2026
Read articleJasper Therapeutics beats Q2 expectations but shares fall after results
InvestorsHub • Aug 17, 2026
Read articleJasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire • Aug 14, 2026
Read article